Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Positive Nodes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05861440
What this trial is testing

Applying Shear Wave Elastography for Adjunct Steroid on Tuberculous Lymphadenitis

Who this might be right for
Tuberculous Lymphadenitis
National Taiwan University Hospital 50
Not applicableLooking for participantsNCT04504006
What this trial is testing

European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III

Who this might be right for
Endometrial Cancer
Dr. Paul Buderath 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07830355
What this trial is testing

Immunotherapy Plus Anlotinib After Surgery for Esophageal Squamous Cell Cancer With Residual Tumor and Positive Lymph Nodes

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 75
Not applicableActive Not RecruitingNCT03513614
What this trial is testing

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)

Who this might be right for
Node-positive Breast Cancer
University Hospital, Basel, Switzerland 1,500
Not applicableEnded earlyNCT01376856
What this trial is testing

Characteristics of Mediastinal Lymph Node With False Positive FDG PET/CT Results in Lung Cancer Staging : Relation With TB and Latent TB Infection

Who this might be right for
Lung Cancer
Yonsei University 33
Large-scale testing (Phase 3)Active Not RecruitingNCT06246344
What this trial is testing

Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Shandong Cancer Hospital and Institute 128
Post-approval studies (Phase 4)UnknownNCT05676866
What this trial is testing

Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy

Who this might be right for
Node-positive Breast Cancer
Assiut University 30
Large-scale testing (Phase 3)Active Not RecruitingNCT00433511
What this trial is testing

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Who this might be right for
Breast Adenocarcinoma
National Cancer Institute (NCI) 4,994
Testing effectiveness (Phase 2)UnknownNCT04659499
What this trial is testing

Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer

Who this might be right for
Early Breast Cancer
Peking Union Medical College Hospital 261
Not applicableLooking for participantsNCT04069884
What this trial is testing

RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer

Who this might be right for
Breast CancerRadiation
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 540
Not applicableStudy completedNCT03355261
What this trial is testing

Positive Node Traced Before Neoadjuvant Chemotherapy (NAC)

Who this might be right for
Breast Cancer
Shengjing Hospital 110
Large-scale testing (Phase 3)Study completedNCT00002542
What this trial is testing

Tamoxifen in Treating Women With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 672
Not applicableNot Yet RecruitingNCT06039956
What this trial is testing

De-escalating Axillary Surgery in Breast Cancer Patients in Nigeria

Who this might be right for
Breast CancerAxilla; Breast
Nova Scotia Health Authority 100
Not applicableStudy completedNCT04743583
What this trial is testing

Prevalence and Malignant Involvement of Calcified Intrathoracic Lymph Nodes in Patients Undergoing Endosonography

Who this might be right for
LymphadenopathyLung CancerSarcoidosis+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 362
Large-scale testing (Phase 3)Looking for participantsNCT06992882
What this trial is testing

A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS)

Who this might be right for
HER2-positive Breast Cancer
Fudan University 2,306
Testing effectiveness (Phase 2)Study completedNCT00490659
What this trial is testing

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 13
Large-scale testing (Phase 3)Active Not RecruitingNCT04622319
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

Who this might be right for
HER2-Positive Primary Breast CancerResidual Invasive Breast Cancer
Daiichi Sankyo 1,600
Large-scale testing (Phase 3)Study completedNCT01668914
What this trial is testing

Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 126
Testing effectiveness (Phase 2)Study completedNCT00193115
What this trial is testing

Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 32
Not applicableLooking for participantsNCT07411729
What this trial is testing

Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions

Who this might be right for
Emerging Infectious DiseasesCommunicable DiseasesBiological Warfare Agents+2 more
Assistance Publique - Hôpitaux de Paris 800
Next Page